IRS2 and Hyperglycemia: The hallmark of insulin resistance in PI3K pathway is the inhibition of the insulin receptors and/or its substrates, especially the insulin receptor substrate 2 (IRS-2) and IRS-1, leading to hyperinsulinemia and hyperglycemia in the peripheral tissues, such as in muscle and adipose tissues [2,25].